Parity, age at first birth, and risk of death from brain cancer: a population-based cohort study in Taiwan by Hui-Fen Chiu et al.
Chiu et al. BMC Public Health 2012, 12:857
http://www.biomedcentral.com/1471-2458/12/857RESEARCH ARTICLE Open AccessParity, age at first birth, and risk of death from
brain cancer: a population-based cohort study
in Taiwan
Hui-Fen Chiu1, Chih-Cheng Chen2, Shang-Shyue Tsai3, Shu-Chen Ho4 and Chun-Yuh Yang4*Abstract
Background: This study was undertaken to examine whether there is an association between parity and age at first
birth and risk of death from brain cancer.
Methods: The study cohort consisted of 1,292,462 women who had a first and singleton childbirth between Jan. 1,
1978 and Dec. 31, 1987. We tracked each woman from the time of their first childbirth to December 31, 2009, and
their vital status was ascertained by linking records with the computerized mortality database. Cox proportional
hazard regression models were used to estimate the hazard ratios (HR) of death from brain cancer associated with
parity and age at first birth.
Results: There were 316 brain cancer deaths during 34,980,246 person-years of follow-up. The mortality rate of
brain cancer was 0.90 cases per 100,000 person-years. The adjusted HR was 1.35 (95% CI= 0.91-2.01) for women
who gave birth between 21 and 25, 1.61 (95% CI=1.05-2.45) for women who gave birth after 25 years of age,
respectively, when compared with women who gave birth less than 20 years. A trend of increasing risk of brain
cancer was seen with increasing age at first birth. The adjusted HR were 0.73 (95% CI= 0.53-0.99) for women who
had 2 children, and 0.60 (95% CI =0.43-0.83) for women with 3 or more births, respectively, when compared with
women who had given birth to only 1 child. There was a significant decreasing trend in the HRs of brain cancer
with increasing parity.
Conclusions: This study provides evidence that reproductive factors (parity and early age at first birth) may confer
a protective effect on the risk of death from brain cancer.Background
In Taiwan, brain cancer is the 15th leading cause of can-
cer mortality for males and the 13th for females [1]. The
age-adjusted mortality rate for brain cancer was 2.0 per
100,000 among males and 1.4 among females in 2009.
There is substantial geographic variation in brain cancer
mortality within the country.
Little is known regarding the etiology of brain cancer.
Ionizing radiation is the most consistently accepted
causal risk factors for brain cancer [2], and this explains
only a small fraction of cases [3], leaving the majority of
cases with unknown causes [4].* Correspondence: chunyuh@kmu.edu.tw
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reproduction in any medium, provided the orThe incidence rate of glioma is about 1.5 times greater
in men than in women [5,6]. The higher incidence in
men becomes evident around the age of female menar-
che, reaching a maximum around the age of menopause
and diminishing thereafter [6], suggesting a possible pro-
tective effects of female hormones on the development
of brain cancer [6]. The influence of sex hormones on
brain cancer risk is supported by the presence of steroid
hormone receptors in both normal and malignant glial
cells [7-9]. Furthermore, studies of transplanted glio-
blastoma cell lines in mice and rats have found signifi-
cantly faster tumor growth rate and poor survival in
males [10,11].
The role of parity and age at first birth in the etiology
of brain cancer in women have received only limited at-
tention in the literature, and the results have been in-
consistent. Some studies reported inverse associationsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[12-14] and others reported no association [4,15-24].
Likewise, reported associations between younger age at
first birth and brain cancer risk have been inconsistent,
with one study reporting decreased risk [17] and others
reporting no association [4,13,14,16,18-22].
To date, there are limited data regarding the relation-
ship between reproductive factors and brain cancer. The
above-mentioned epidemiologic studies have been con-
ducted on high-incidence populations in Europe and
North America and study results have not been consist-
ent. The present study was carried out because no stud-
ies have been conducted on low-incidence populations
such as Asians. We studied a cohort of women who
experienced a first and singleton childbirth between
January 1, 1978 and December 31, 1987 to explore fur-
ther the association between parity, age at first birth and
the risk of brain cancer in Taiwan.
Methods
Data source
Registration of births is required by law in Taiwan. It is
the responsibility of the parents or the family to register
infant births at a local household registration office
within 15 days. The Birth Registration System, which is
managed by the Department of Interior, released compu-
terized data on live births since 1978. The registration
form, which requests information on maternal age, edu-
cation, parity, gestational age, date of delivery, infant
gender, and birth weight, is completed by the physician
attending the delivery. Because most deliveries in Taiwan
take place in either a hospital or clinic [25] and the birth
certificates are completed by physicians attending the
delivery and it is mandatory to register all live births at
local household registration offices, the birth registration
data are considered complete, reliable and accurate.
These data have been used in our previous studies
[26,27].
Study population
The study cohort consisted of all women with a record
of a first and singleton childbirth in the Birth Register
between January 1, 1978 and December 31, 1987.
There were 1,333,312 first and singleton births oc-
curred in Taiwan between 1978–1987. Information on
any subsequent births was also retrieved from the Birth
Register. Of the 1,399,312 primiparous women, 106,850
subjects were excluded because data were missing on
at least one variable such as maternal age (n=100,099),
years of schooling (n=382), marital status (n=2665), or
birth place (n=4535). These exclusion left 1,292,462
women with complete information for the analysis.
Their details have already been described in an earlier
publication [27].Follow-up
Each woman has her own unique personal identification
number. Using this number, we tracked each woman
from the time of their first childbirth to December 31,
2009, and their vital status was ascertained by linking
records with the computerized mortality database, iden-
tifying the date of any deaths occurring in this cohort.
Of the 1,292,462 women followed, none had a missing
personal identification number; therefore, all cohort
members were followed up. Since it is mandatory to
register death certificates at local household registration
offices, the mortality statistics in Taiwan were consid-
ered to be highly accurate and complete [28].
Statistics
The person-years of follow-up for each woman was cal-
culated from the date of first childbirth to the date of
death or December 31, 2009. Death rates were calculated
by dividing the number of deaths from brain cancer by
the number of person-years of follow-up. Cox propor-
tional hazard regression models were used to estimate
the hazard ratios (HRs) of death from brain cancer asso-
ciated with parity (the number of children recorded in
the last childbirth record of each woman registered dur-
ing follow-up) and age at first childbirth. The 95% confi-
dence intervals (CIs) for the RRs were also calculated.
Brain cancer is defined according to the International
Classification of Disease, Injury, and Causes of Death
(9th revision) (ICD code 191). It includes malignant neo-
plasm of the cerebrum, except lobes and ventricles
(191.0); malignant neoplasm of the frontal lobe (191.1);
malignant neoplasm of the temporal lobe (191.2); malig-
nant neoplasm of the parietal lobe (191.3); malignant
neoplasm of the occipital lobe (191.4); malignant neo-
plasm of the ventricle (191.5); malignant neoplasm of
the cerebellum (191.6); malignant neoplasm of the brain
stem (191.7); malignant neoplasm of other parts of brain
(191.8); and malignant neoplasm of brain, unspecified
(191.9). The variables in the final model included age at
first childbirth (≤ 20, 21–25, > 25), parity (1, 2, 3 or
more), marital status (married, unmarried), years of
schooling (≤9, > 9 years), and birth place (hospital/clinic,
home/other). The proportional hazards assumption was
assessed for all above-mentioned variables, and no viola-
tions were observed. Analyses were performed using the
SAS statistical package (version 9.2, SAS Institute Inc).
All statistical tests were two-sided; p values of less than
< 0.05 were considered to be statistically significant.
Results
Altogether 1,292,462 primiparous women with complete
information were included in the analysis. A total of
34,980,246 person-years were observed during the follow-
up period from the time of their first childbirth to
Table 2 Association between parity, age at first birth, and
relative risk of death from brain cancer over a 32-year
follow-up period
Variables Crude HR (95%CI) Multivariate-Adjusted
HR* (95% CI)
Age at recruitment (1st birth)
≤ 20 1.00 1.00
21-25 1.36 (0.92~2.01) 1.35 (0.91~2.01)
> 25 1.73 (1.16~2.58) 1.61 (1.05~2.45)
p=0.0034 for linear trend p=0.0238 for linear trend
Parity
1 1.00 1.00
2 0.71 (0.52~0.97) 0.73 (0.53~0.99)
3+ 0.56 (0.41~0.78) 0.60 (0.43~0.83)






0.89 (0.42~1.88) 0.81 (0.38~1.73)
Years of
schooling
≤ 9 y 1.00 1.00
> 9y 1.07 (0.86~1.34) 0.93 (0.73~1.18)
Birth place
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yielding a mortality rate of 0.90 cases per 100,000 person-
years.
Table 1 gives the numbers of person-years of follow-
up and brain cancer deaths by age at recruitment (age at
first birth), parity, marital status, years of schooling, and
birth place. The mortality rate was 1.32 among women
who had given birth to one child, 0.94 among those who
had had two children, and 0.76 among those who had
given birth to 3 or more children.
The multivariate-adjusted HR and 95% CIs are shown
in Table 2. An older age at first birth was associated with
an increased brain cancer risk. The adjusted HR was
1.35 (95% CI= 0.91-2.01) for women who gave birth be-
tween 21 and 25 years, 1.61 (95% CI=1.05-2.45) for
women who gave birth after 25 years, respectively, when
compared with women who gave birth younger than 20
years. A trend of increasing risk of brain cancer was seen
with increasing age at first birth (p for trend=0.024).
After adjustment for age at first birth, marital status,
years of schooling, and birth place, the adjusted HR were
0.73 (95% CI= 0.53-0.99) for women who had 2 children,
and 0.60 (95% CI =0.43-0.83) for women with 3 or more
births, respectively, when compared with women who
had given birth to only 1 child. There was a statistically
significant decreasing trend in the adjusted HRs for











Age at recruitment (1st birth)
≤ 20 158,292 4,544,456.00 30 0.66
21-25 701,650 19,032,158.50 164 0.86
> 25 432,520 11,403,631.50 122 1.07
Parity
1 157,207 4,170,772.33 55 1.32
2 564,727 15,124,112.33 142 0.94
3+ 570,528 15,685,361.33 119 0.76
Marital
status
Married 1,260,615 34,115,479.25 309 0.91
Not married 31,847 864,766.75 7 0.81
Years of schooling
≤ 9y 722,518 19,850,938.17 176 0.89




1,245,925 33,638,862.83 303 0.90
Home /
other






1.03 (0.59~1.80) 1.16 (0.66~2.03)
* mutually adjusted.Discussion
To our knowledge, this is the largest cohort (n=1,292,462
women) published to date to examine the relationship
between reproductive factors (parity and age at first
birth) and brain cancer risk. In this prospective cohort
study, we found a statistically significant decreased risk
of brain cancer with increasing parity. Our findings of a
reduced risk of brain cancer associated with higher parity
is in agreement with previous studies [12-14], but is not
in agreement with other studies that reported no associ-
ation with parity [4,15-24].
The mechanism by which increased parity may confer
protection against the future development of brain can-
cer in women remains unclear. Pregnancy elevates
serum estrogen levels approximately 100-fold [29]. In-
creasing parity is associated with an overall increase in
lifetime estrogen exposure. There is experimental evi-
dence that estrogen inhibits proliferation of glioma
[30,31] and induces cell death [30,32]. In addition, estro-
gen has been shown to reduce glutamate toxicity in glial
cells [33] and speeds up the process of repair after brain
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reduced risk of brain cancer, we would expect pregnancy
to offer some protection from brain cancer. Our data
provide support for this hypothesis. However, it is un-
known whether estrogen or other hormones play a role
in the development of brain cancer. Support for a pos-
sible role of sex hormones in gliogenesis comes from the
fact that some gliomas express estrogen receptors [7,9].
Furthermore, aromatase, an enzyme with high levels in
human and rat glioblastomas, can convert testosterone
to estradiol [35].
In the present prospective cohort study, we found that
risk of brain cancer increased with increasing age at first
birth after adjusting for parity. Our finding of a positive
association between age at first birth and brain cancer
risk agrees with one previous study [17] but not with
other studies that reported no association with age at
first birth [4,13,14,16,18-24]. The reasons are unknown.
It may be that a younger age at first birth played a pro-
tective role in brain cancer risk via elevated levels of
some hormones (including estrogen and progesterone)
during pregnancy. Moreover, it has been found that age
at menarche (and thus exposure to period estrogens
stimulation) is related to age at which a women delivers
her first child [36]. Earlier exposure to regular menstrual
cycles and the concomitant earlier increase in exposure
to estrogens may protect against tumor initiation during
this early life stage [17]. Our finding of an increased risk
of brain cancer associated with older age at first birth is
in keeping with the hypothesis that estrogen exposure is
protective with respect to brain cancer risk. However,
because there is only limited evidence to date for a posi-
tive association between age at first birth and risk of
death from brain cancer, the possibility that this is a
chance finding also needs to be considered. Clearly,
more work will be needed before the influence of age at
first birth on the risk of brain cancer is understood.
To our knowledge, ours is the first prospective cohort
study to report a protective effect of parity and early age
at first birth on the subsequent risk of death from brain
cancer. However, these results are inconsistent with
most studies published to date. The reasons for these
differences in findings are unknown. Only three pro-
spective studies have examined the relationship between
parity and age at first birth and brain cancer risk
[18,19,22]. Most of previous studies used case–control
design [4,12-17,20,21,23,24]. The main strength of this
investigation is its prospective study design, which elimi-
nates the possibility of recall bias. Also, the complete
population coverage and follow-up made possible by the
national identification number has left the study without
selection bias. The mean age at baseline was 24.33 years
in this study. Women included in our study tended to
be younger than those in previous cohort studies(ranging from 48.5 to 55.9 [18,19,22]. In addition, the
number and type of potential confounders taken into ac-
count varied between studies. The relative risk estimate
may therefore be different between studies [37]. Also, in-
formation on exogenous hormone use (the use of oral
contraceptives (OC) and hormone replacement therapy
(HRT)) and cumulative number of menstrual cycles (age
at menarch and menopause) were not available in this
study. Previous prospective cohort studies have included
all different exposures in a multivariate analysis. This
analysis could help to better assess effect of each hormo-
nal factor. Finally, age at first birth may be different in
different countries and during different periods. The
mean age at first birth was 24.33 in our cohort. This
value was increased during the study period (ranged
from 23.3 to 28.1 in 2006). Likewise, same temporal dif-
ferences may exist for European countries.
Mortality data have been widely used to generate epi-
demiologic hypotheses, despite their inherent limita-
tions. The completeness and accuracy of the death
registration system should be evaluated before any con-
clusion based on the mortality analysis is made. In the
event of a death in Taiwan, the decedent’s family is
required to obtain a death certificate from the hospital
or local community clinic, which then must be submit-
ted to the household registration office in order to can-
cel the decedent’s household registration. The death
certificate is required in order to have the decedent’s
body buried or cremated. Death certificates must be
completed by physicians in Taiwan. It is also mandatory
to register all deaths at local household registration
offices, the death registration is accurate, reliable and
complete.
Taiwan is a small island with a convenient communi-
cation network. It is believed that all brain cancer cases
had access to medical care. Mortality data rather than
data on inpatient cases was used to assess the associ-
ation between parity, age at first birth, and brain cancer
in this study. The mortality of a disease is a function of
its incidence and fatality. The 5-year survival rate for
brain cancer has been reported to be as low as 30% in
United States [2]. Deaths from brain cancer may there-
fore be regarded as a reasonable indicator of the inci-
dence of brain cancer.
Several studies have found that the use of OCs was
associated with a reduced risk of brain cancer [15,17,21].
Other studies, however, have failed to find statistically
significant association between the use of OCs and brain
cancer [3,4,16,18,19,22]. Regarding HRT, previous stud-
ies have largely reported no association between HRT
and brain cancer risk [3,4,16-18,22]. We were unable to
adjust for these two hormonal factors in the current
study due to the lack of available data. Since the use of
OC and HRT are low in Taiwan compared with Western
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these two factors should be small, if any exists at all.
Furthermore, if the association between these two po-
tential confounding variables and the risk of brain can-
cer is not as strong as the one that has been observed
for parity and age at first birth, adjustment of these vari-
ables will not qualitatively change the conclusion.
Smoking was associated with the incidence of brain
tumors [40-42]. There is unfortunately no information
available on individual smoking habits and thus it could
not be adjusted in the analysis. The smoking prevalence
for females was only about 4.2% in Taiwan [43]. We
think that the degree to which not controlling for this
variable may have affected our results should be small if
it existed at all. Nevertheless, the problem of possible
confounding from smoking should be evaluated. Smok-
ing habits account for at least part of the socioeconomic
differentials, with rates of smoking considerably higher
among those with lower levels of education. In this
study, years of schooling was used as a proxy for socioe-
conomic status and was included as a control variable in
the multivariate analysis. We therefore may have par-
tially indirectly adjusted for the confounding effect
resulting from smoking.
Ionizing radiation, occupational exposure to solvents,
and electromagnetic fields are the most important risk
factors for brain cancer [2]. There is no information
available on these variables for individual study subjects
and thus they could not be adjusted for in the analysis.
However, there is no reason to believe that there would
be any correlation between these variables and parity
and age at first birth.
Some potential limitations of this study needed to be
noted. First, our computerized death-certificate database
does not specify the tumor type and the histological
classification for the brain cancer cases. We therefore
could not estimate the risk of brain cancer in more de-
tail in relation to risk for specific brain cancer subtypes.
Second, data on the accuracy of brain cancer diagnosis
are not available in Taiwan and misclassification is pos-
sible. However, this misclassification is likely to be non-
differential (i.e., unlikely to be related parity) and
therefore would tend to underestimate rather overesti-
mate the true association. Third, Taiwan’s vital records
and birth registration system covers only live births and
exclude stillbirths and abortions. We were therefore un-
able to examine the possible role of gravidity on the
brain cancer risk. Fourth, by design, our study focused
solely on mortality among parous women. We were un-
able to examine the possible role of nulliparity on the
risk of brain cancer. The generalizability of our findings
is thus limited. Fifth, although the number of person-
years are large, the number of of brain cancer deaths is
relatively small (n=316). The power of this study wastherefore relatively limited. The possibility that this is a
chance finding also needs to be considered.
Conclusion
We found that there was a trend for increasing parity to
be associated with decreasing risk for brain cancer. In
addition, we found that risk for brain cancer increased
with increasing age at first birth. This study provides evi-
dence that reproductive factors (parity and early age at
first birth) may confer a protective effect on the risk of
brain cancer.
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